//
Cardiovascular Aging and Heart Failure: JACC Review Topic of the Week
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation
Association of Reduced Apical Untwisting With Incident HF in Asymptomatic Patients With HF Risk Factors
Dapagliflozin for treating chronic heart failure with reduced ejection fraction
Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial
Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators - The RAID Trial